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Abstract. The ability to predict the progression of biomarkers, notably
in NDD, is limited by the size of the longitudinal data sets, in terms of
number of patients, number of visits per patients and total follow-up
time. To this end, we introduce a data augmentation technique that is
able to reproduce the variability seen in a longitudinal training data
set and simulate continuous biomarkers trajectories for any number of
virtual patients. Thanks to this simulation framework, we propose to
transform the training set into a simulated data set with more patients,
more time-points per patient and longer follow-up duration. We illustrate
this approach on the prediction of the MMSE of MCI subjects of the
ADNI data set. We show that it allows to reach predictions with errors
comparable to the noise in the data, estimated in test/retest studies,
achieving a improvement of 37% of the mean absolute error compared
to the same non-augmented model.
Keywords: Data augmentation · Sequence data · Virtual cohort · Dis-
ease stage prediction · Alzheimer’s Disease
1 Introduction
Predicting the future progression of patients with neurodegenerative diseases
(NDD) is a key challenge to treat patients at an earlier stage than today or to
better evaluate drug efficacy in clinical trials. Longitudinal data sets, consisting
of repeated observations of the same patients over time, play a central role to
describe and predict disease progression. Machine Learning techniques, trained
on sequence data (multiple observations per patient), have seize this challenge.
However, the databases often lack patients with sufficient follow-up visits, a fu-
ture visit to predict and a sufficiently large delay in between, leading to poor
generalization on test data. More importantly, the different experimental set-
tings - time to prediction or patients/visits presenting the considered feature(s)
- are difficult to compare as they involve a subset of the initial cohort that has
specific characteristics in terms of number of patients, number of follow-up visits
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and duration. It is often impossible to balance the training and test set for all
these characteristics. This problem prevents from a reliable comparison of the al-
gorithms, some being better due to the size or characteristics of the training set,
rather than the intrinsic performance of the algorithm or choice of the features.
To increase the size of real data sets, data augmentation techniques have
been developed : virtual data are drawn with the intention to reproduce the
characteristics of the data in the initial cohort. Most of the literature focuses
on techniques for independent and identically distributed observations such as
image classification [7], text categorization [6] or speech recognition [3]. Due to
the unrealistic hypothesis for sequence data, some techniques have been proposed
for uni-dimensional time-series. They rely on a continuous transformation of the
time domain by warping, slicing or sliding the time window [5]. Such techniques
do not apply to NDD as the temporal pattern is key in the disease progression.
Recently, Generative Adversarial Networks (GAN) have received interest due
to the characteristic of the generative part of the model: it can sample virtual
realistic data. It is however non-trivial to generate sequence data as there is no
straightforward way to propagate the gradient updates from the discriminator
to the generator [10]. Furthermore, these models rely on large training data sets,
which are typically inaccessible in the targeted medical applications.
In this paper, we propose to use a simulation framework to perform data
augmentation for sequence data in the presence of small training samples, and to
evaluate to which extend it increases the performance of a predictive algorithm.
The model introduced in [9] recombines short-term individual observations at
different disease stages to estimate a long-term scenario of disease progression.
The model estimates also parameters that change the pattern of progression, the
pace of progression and the age at onset, so that it can reconstruct a continuous
trajectory by fitting individual data, or simulate entirely synthetic trajectories by
sampling the empirical distribution of the parameters. This model, once trained
on a small and unbalanced training data set, may be used therefore to re-sample
the trajectories of the training subjects by adding new visits and covering larger
time span, and even increase the number of subjects by adding data sampled
from simulated trajectories. This augmented virtual cohort may then be used
in lieu of the training samples to train a predictive algorithm. We propose to
evaluate the performance of the algorithm trained with this augmented and
virtualized data, as compared to the original training set, for the prediction of
the cognitive decline in subjects with mild cognitive impairments.
2 Sequence-based prediction
In the following, we consider a longitudinal data set y = (yij , tij) 1≤i≤n
1≤j≤ni
where
the i−th subject has been observed ni times at ages t1i < · · · < tini with
yij ∈ Rd a set of biomarkers. Each observation corresponds to a snapshot of
the individual spatiotemporal trajectory. We aim to predict the value of one
biomarker in ∆T years after a given visit, knowing the values of the biomarkers
at the previous visits.
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Fig. 1. The top row describes the standard prediction setting where the data set is
split in a train and test set. A fixed time-delay ∆T is set between the input visits (blue
dots) and the target prediction (red dot). It leads to discarding visits in between (grey
dots) or entire subjects that do not present sufficient follow up visits (discarded set).
The bottom row corresponds to the procedure with simulated data : the training set
is composed of virtual patients that are simulated thanks to the estimation set.
2.1 Standard prediction setting
In a standard setting, one needs to discard patients that do not have suffi-
cient follow-up visits to cover the required temporal span, i.e. tini − ti1 < ∆T ,
as shown on the top row of Figure 1. For the remaining patients, the input
biomarkers (yij)1≤j≤ki at some early visits (tij)1≤j≤ki (blue dots) are used to
predict the biomarker yip∗i at age tip∗i (red dot) such that tip∗i = tiki + ∆T .
This task may be achieved by any machine learning algorithm, for instance a
neural network. In this setting, possible intermediate visits tij such that tiki <
tij < tip∗i are discarded (grey dots). If multiple splits of input/output visits
((yij , tij)1≤j≤ki , (yip∗i , tip∗i )) are possible, one is selected at random. Once the
input and target visits have been selected for each patient, they are split into
the train and test set.
The longer ∆T , the fewer patients remain in the train and test set and the
fewer visits per remaining patients there are. Therefore, when ∆T is varied, the
size and composition of the train and test set may vary dramatically, and thus
the performance of the predictive algorithm. This problem is even more critical
if several biomarkers that are not observed at every visit are used.
2.2 Sequence data simulation
We consider a generative mixed-effect model such that the individual observa-
tions at time-point tij is yij = f(θ, zi, tij) + ij , ij
i.i.d.∼ N (0, σ2Idd) where θ
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corresponds to the fixed-effects and zi the random effects associated to the sub-
ject i. Assuming that it is possible to estimate θ and (zi)1≤i≤n given a training
data set, we can draw a new sample zi′ from the empirical distribution of the
(zi)1≤i≤n. It corresponds to a new individual for which is it possible to simulate
new observations at arbitrary time-point (ti′j)1≤j≤ni′ .
An example of such model is introduced in [9], where the authors consider
that the fixed-effects θ define the group-average disease progression and its vari-
ability in the population. This fixed-effects, of small dimension relatively to the
feature space, can be estimated, thanks to the MCMC-SAEM [1,4], with short-
term observations for a relatively small number of subjects. As for the i-th indi-
vidual trajectory, the authors consider that it derives from the group-average tra-
jectory according to the random-effects zi = (αi, τi, (sij)1≤j≤Ns) where αi corre-
sponds to the pace of progression and τi relates about the time delay between the
group-average and the individual scenario. On top of these temporal parameters
that impact the observation coordinates similarly, the space-shifts (sij)1≤j≤Ns
characterize the inter-coordinates variations (Ns ≤ N). These random-effects are
learnt by optimizing the individual complete likelihood p((yij)1≤j≤ni , zi; θ) =
p((yij)1≤j≤ni |zi; θ)p(zi; θ) thanks to the L-BFGS-B method [11].
It is possible to draw a set of individual parameters zi′ by, first, simulating
the temporal parameters (αi′ , τi′) with a kernel density estimation on the em-
pirical distribution (αi, τi)1≤i≤n. Then, considering the multivariate Gaussian
distribution N (µ,Σ) estimated on the whole learnt random effects (zi)1≤i≤n, it
is possible to draw ((si′j)1≤j≤Ns |αi′ , τi′) ∼ N (µ˜, Σ˜) where µ˜ and Σ˜ are functions
of µ and Σ [8].
2.3 Prediction setting with simulated patients
From the whole data set, we first select an estimation subset that includes the
subjects that were discarded in the standard procedure along with some subjects
that have more follow-up duration, as shown on the bottom row of Figure 1. The
remaining subjects form the test set, with same split constraints on the input
and target visits as in the standard prediction setting.
Once θ and (zi)1≤i≤n are learnt on the estimation set, we can simulate an
arbitrary number of patients and visits per individual that will be used as the
training set. To have similar characteristics in the training and test set, the time
between two simulated visits is kept similar to the one of the real patient (e.g.
one year), and, the input and target visits are split as before. It is important to
mention that the estimation procedure now uses the visits tij such that tiki <
tij < tij∗ that were previously discarded (grey dots).
In the following, to assess the quality of the simulated data only, we prevent
ourselves from using patients from the estimation set that are eligible in term of
number of visits to be used in the training set (upper part of the estimation set
of Figure 1) : that the training procedure relies on the simulated patients only.
In other cases, it is indeed possible - and recommended - to add them to the
training set.
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(a) Normalized ADAS 11
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(b) Normalized MMSE
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(c) Normalized MOCA
Fig. 2. Empirical histograms and cumulative distributions of original cohort (blue)
and of the simulated data (red) based on a model that estimate the evolution of the
normalized ADAS Cog with 11 and 13 items and the normalized MOCA.
3 Experimental results
3.1 Data and experimental setting
The experiments focus on the prediction of the mini-mental state examination
(MMSE) for subjects with mild cognitive impairment (MCI) from the ADNI
database. Therefore, our cohort includes early and late MCI, but also MCI who
converted to Alzheimer’s Disease and stable MCI. We considered predictions at
1, 2, 3 and 4 years, based on a set of features among the MMSE, Alzheimer’s
disease assessment scale - cognitive subscale (ADAS-Cog) with 11 or 13 items,
clinical dementia rating sum of boxes (CDRSB), the Montreal cognitive assess-
ment (MOCA) and the functional assessment questionnaire (FAQ). One estima-
tion set was defined per subset of features used in the predictive model, e.g. an
estimation set that simulate patients with MMSE, ADAS-11 and ADAS-13 was
defined for the predictions that are based on these features.
To assess the performance of the simulation framework, we create a virtual
cohort with the same characteristics (number of patients and time-points) as the
estimation set. The empirical data distribution for the real and virtual cohort
are nearly identical as shown on Figure 2 for three different features.
We choose a long short-term memory (LSTM) neural network, with 10 hid-
den dimensions, stacked with a linear layer, as our algorithm to predict future
feature values. The Mean Squared Error (L2-norm) loss is optimized thanks to
the ADAM optimizer (learning rate of 10−3 and weighted decay of 10−5). To
prevent the model from overfitting, a subset of the real patients, namely the
validation set, is used to apply the early stopping criterion procedure : it stops
the training if no loss improvement is detected from a given number of epoch on
the validation set. The code is available at [shown after paper acceptance].
The results report the Mean Absolute Error (MAE). To estimate the variance
of the estimation procedure, the results are presented with error-bars correspond-
ing to the mean and standard deviation of 10 independent runs with different
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test splits. The results are compared to, first, the constant prediction, i.e. the
hypothesis that there is no change of MMSE within the time interval, and, on
the other side, the noise in the data. For the MMSE, [2] reports two noise val-
ues : a standard deviation of 1.3 and 2.8 (out of 30) for respectively cognitively
normal and MCI patients. Once normalized and converted to absolute values,
it corresponds to MAE errors of 0.035 and 0.074, represented by a pale orange
interval on Figures 3 and 4.
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(b) Augmented data
Fig. 3. Prediction of the MMSE in 1 (blue), 2 (orange), 3 (green) and 4 (red) years
with different sets of variables (upper part of each column). The colored dashed lines
corresponds to the error for the corresponding constant prediction. The pale orange
area corresponds to the noise interval in the data. The number at the bottom presents
the training and test set sizes.
3.2 Prediction of MMSE
The prediction accuracy in the standard prediction setting, without simulated
patients, are presented on Figure 3a. The different columns correspond to dif-
ferent sets of markers used as input. It is possible to reach noise level prediction
up to 2 years in advance with the MMSE, ADAS-11, ADAS-13, MOCA, FAQ
and CDRSB. At 3 and 4 years, the prediction, although often better than the
constant prediction, is still larger than noise level.
Replacing the training set by a simulated cohort leads to a significant im-
provement of the prediction, as first shown on Figure 4. It corresponds to a
decrease of the MAE of 20% (resp. 37%) for prediction 3 years (resp. 4 years)
in advance. As the part of the patients used in the estimation set may vary,
we tested different scenarios that lead to better results when more patients were
used. On the contrary, the number of simulated patients does not seem to have a
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Fig. 4. MMSE prediction based on MMSE, ADAS-11, ADAS-13, MOCA, FAQ and
CRDSB. The red value on the left corresponds to the MAE without simulated data.
Then, each column corresponds to a different size of the estimation set. Within each
column, we simulate, from left to right, 50, 100, 250, 500 and 1000 virtual patients.
great impact on the quality of the prediction. A possible but preliminary expla-
nation lies in the fact that even though there are not a lot of simulated patients,
they already incorporate more (simulated) visits than real patients.
3.3 Fair comparison of algorithms
To better exhibit the problem of comparison between different prediction set-
tings, we refer to Figure 3a where the lower figures represent the number of
training and test patients in the related model. These numbers decrease for
longer time to prediction but also for different sets of features, as not all the
examinations have been assessed at each patients’ visit.
To solve this issue, we simulated 500 virtual patients for each scenario and
estimated the MAE on real patients, as shown on Figure 3b. The prediction at
3 and 4 years on the left column corresponds to the values of Figure 4. The
first result to notice, comparatively to 3a, is that the MAE variance over the 10
runs is reduced, probably due to the increased test set. More interestingly, the
predictive power of the ADAS-11, ADAS-13 and MMSE is not better than with
the MMSE alone, a result that could not have been stated from the standard
prediction. It essentially means that the MMSE alone is a predictor as good as
the three variables but needs more patients to train the model on. In the same
spirit, FAQ, MOCA and/or CDRSB provide substantial information that allow
to reach noise level prediction up to 4 years in advance.
4 Discussion
We proposed a data augmentation technique for small data sets that allow to
increase the accuracy of the MMSE prediction for MCI subjects. We believe
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this technique to be a milestone in the ability to accurately compare various
algorithms and features for different time to prediction, as it helps simulating
training cohort that are comparable in terms of number of subjects, number of
visits per subject and overall follow-up duration.
In this regard, we need to further evaluate the simulation procedure by mea-
suring, for instance, the impact of the number of visits simulated, the time-
interval between them, or the selection of the first visit. This could benefit other
studies by providing a more accurate comparison of the predictive quality of
models or new biomarkers. Overall, it gives a better idea of the generalisation
errors of such predictive algorithms in a real clinical setting.
This work has been partly funded by ERC grant No678304, H2020
EU grant No666992, and ANR grant ANR-10-IAIHU-06.
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